Torilis japonica Extract Suppresses the Induction of Atopic Inflammation
International Journal of Molecular Sciences · 20.01.2023 · 24 (3) · 2102
DOI: 10.3390/ijms24032102 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.01.2023. Verfasst von Ji-Won Seo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science and Biotechnology, College of Life Science and Nano Technology, Hannam University, Daejeon 34054, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Commercializations Promotion Agency for R&D Outcomes(COMPA), Commercializations Promotion Agency for R&D Outcomes (COMPA).
Abstract (Originalsprache)
As one of the major intractable allergic disorders, atopic inflammation is commonly accompanied by itching, dry skin, and inflammation. Atopic inflammation deteriorates the quality of life and has no fundamental cure, so it is crucial to urgently explore and develop natural resources for long-term treatment without any side effects. This study aimed to verify Torilis japonica extract (TJE)’s relieving effect and mechanism against atopic inflammation using skin cells and skin equivalent models, as well as to investigate torilin’s effect (obtained from TJE) and other unknown components as marker compounds. Torilin concentration was verified in TJE using high-performance liquid chromatography and analyzed the unknown components using nuclear magnetic resonance spectroscopy. Furthermore, TJE’s cytotoxicity, regenerative effect, and cell cycle regulation effects were confirmed using skin cells with atopic inflammation (human dermal fibroblasts and HaCaT keratinocytes) by using TNF-α and IFN-γ treatments. Consequently, TJE was demonstrated to regulate TARC and CTACK expressions as chemokines and those of interleukin-4, -5, and -13 as cytokines related to atopic inflammation. TJE was further confirmed to affect the matrix metalloproteinase-1, -2, and -9 expressions, which are essential in skin damage. Lastly, this study confirmed TJE’s relieving effect against atopic inflammation through a 3D skin model and RhCE model using human dermal fibroblasts and HaCaT keratinocytes. These findings on atopic inflammation verified torilin’s relieving effects and TJE’s other components.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science and Biotechnology, College of Life Science and Nano Technology, Hannam University, Daejeon 34054, Republic of Korea.
ORCID-Profile: Ji-Won Seo, Hyo-Jae Lee, Gun-He Nam
Förderung
- Commercializations Promotion Agency for R&D Outcomes(COMPA)
- Commercializations Promotion Agency for R&D Outcomes (COMPA)
Zitieren
APA
Seo, J. W., Lee, H. J., Youk, Y. M., Nam, G. H., & Kim, Y. M. (2023). Torilis japonica Extract Suppresses the Induction of Atopic Inflammation. International Journal of Molecular Sciences, 24(3), 2102. https://doi.org/10.3390/ijms24032102
Vancouver
Seo JW, Lee HJ, Youk YM, Nam GH, Kim YM. Torilis japonica Extract Suppresses the Induction of Atopic Inflammation. International Journal of Molecular Sciences. 2023;24(3):2102. doi:10.3390/ijms24032102
BibTeX
@article{Seo2023,
author = {Seo, Ji-Won and Lee, Hyo-Jae and Youk, Young-Mi and Nam, Gun-He and Kim, Young-Min},
title = {Torilis japonica Extract Suppresses the Induction of Atopic Inflammation},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2102},
doi = {10.3390/ijms24032102}
}
EUVIMED